Across TCGA patient cohorts, PCDHA9 mutation is significantly associated with the RNA expression of many other genes, with 7,619 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible PCDHA9-associated genes across cancer lineages are BMS1, KIF9-AS1, and GXYLT1. Each is linked with PCDHA9 in more than 5 cancer types. Because this analysis shows association rather than direction, both PCDHA9-to-partner and partner-to-PCDHA9 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PCDHA9→partner) and Y-score (partner→PCDHA9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
STAD	BMS1 →	+0.539	+3.712	<.001	<.001	3	6
BLCA	KIF9-AS1 →	+0.243	+2.415	.008	.002	3	5
BLCA	GXYLT1 →	+0.518	+2.329	.001	.003	3	5
UCEC	DONSON →	+0.426	+1.247	<.001	<.001	3	5
UCEC	SPATA5L1 →	+0.361	+1.174	<.001	<.001	3	5
STAD	SPDL1 →	+0.478	+3.713	.002	<.001	3	5

Each partner links to its Q-omics profile. Showing the 6 strongest of 7,619 associations by consensus.

Exploration

PCDHA9 survival (RNA) · tumor vs normal (RNA) · all PCDHA9 data types